Literature DB >> 24304324

Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.

G Di Nardo1, G Barbara, S Cucchiara, C Cremon, R J Shulman, S Isoldi, L Zecchi, L Drago, S Oliva, R Saulle, M R Barbaro, L Stronati.   

Abstract

BACKGROUND: Neuroimmune interactions and inflammation have been proposed as factors involved in sensory-motor dysfunction and symptom generation in adult irritable bowel syndrome (IBS) patients. In children with IBS and healthy controls, we measured ileocolonic mast cell infiltration and fecal calprotectin and evaluated the relationships between these parameters and abdominal pain symptoms and stooling pattern.
METHODS: Irritable bowel syndrome patients diagnosed according to Pediatric Rome III criteria and healthy controls kept a 2-week pain/stooling diary. Ileocolonic mucosal mast cells (MC) and MC in close proximity to nerve fibers (MC-NF) were identified immunohistochemically and quantified. Fecal calprotectin concentration was measured. KEY
RESULTS: 21 IBS patients and 10 controls were enrolled. The MC-NF count was significantly higher in the ileum (p = 0.01), right colon (p = 0.04), and left colon (p < 0.001) of IBS patients compared with controls. No differences in fecal calprotectin concentration were noted. Abdominal pain intensity score correlated with ileal MC count (r(s) = 0.47, p = 0.030) and right colon MC-NF count (r(s) = 0.52, p = 0.015). In addition, children with IBS with >3 abdominal pain episodes/week had greater ileal (p = 0.002) and right colonic (p = 0.01) MC counts and greater ileal (p = 0.05) and right colonic (p = 0.016) MC-NF counts than children with less frequent pain. No relationship was found between MC and MC-NF and fecal calprotectin or stooling pattern. CONCLUSIONS & INFERENCES: Mast cells-nerve fibers counts are increased in the ileocolonic mucosa of children with IBS. Mast cells and MC-NF counts are related to the intensity and frequency of abdominal pain.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  children; functional gastrointestinal disorders; inflammation; irritable bowel syndrome

Mesh:

Substances:

Year:  2013        PMID: 24304324     DOI: 10.1111/nmo.12250

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  17 in total

Review 1.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 2.  Measuring the symptoms of pediatric constipation and irritable bowel syndrome with constipation: expert commentary and literature review.

Authors:  Robert A Arbuckle; Robyn T Carson; Linda Abetz-Webb; Jeffrey Hyams; Carlo Di Lorenzo; Barbara E Lewis; Elizabeth Gargon; Caroline Kurtz; Steven J Shiff; Jeffrey M Johnston
Journal:  Patient       Date:  2014       Impact factor: 3.883

3.  Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses.

Authors:  J E Medland; C S Pohl; L L Edwards; S Frandsen; K Bagley; Y Li; A J Moeser
Journal:  Neurogastroenterol Motil       Date:  2016-05-02       Impact factor: 3.598

4.  Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.

Authors:  Robert J Shulman; Lena Öhman; Mats Stridsberg; Kevin Cain; Magnus Simrén; Margaret Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2018-10-09       Impact factor: 3.598

Review 5.  Update on Dietary Management of Childhood Functional Abdominal Pain Disorders.

Authors:  Bruno P Chumpitazi
Journal:  Gastroenterol Clin North Am       Date:  2018-09-28       Impact factor: 3.806

6.  Mast cell-nerve interaction in the colon of Trypanosoma cruzi-infected individuals with chagasic megacolon.

Authors:  Patrícia Rocha Martins; Rodolfo Duarte Nascimento; Aline Tomaz Dos Santos; Enio Chaves de Oliveira; Patricia Massara Martinelli; Débora d'Avila Reis
Journal:  Parasitol Res       Date:  2018-02-22       Impact factor: 2.289

Review 7.  Neuroimmune pharmacological approaches.

Authors:  Peter Holzer; Ahmed M Hassan; Piyush Jain; Florian Reichmann; Aitak Farzi
Journal:  Curr Opin Pharmacol       Date:  2015-09-29       Impact factor: 5.547

Review 8.  Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.

Authors:  William L Hasler; Gintautas Grabauskas; Prashant Singh; Chung Owyang
Journal:  Neurogastroenterol Motil       Date:  2022-03-21       Impact factor: 3.960

9.  Involvement of Mast Cells in the Pathophysiology of Pain.

Authors:  Lijia Mai; Qing Liu; Fang Huang; Hongwen He; Wenguo Fan
Journal:  Front Cell Neurosci       Date:  2021-06-10       Impact factor: 5.505

10.  Activation of the Innate Immune System in Children With Irritable Bowel Syndrome Evidenced by Increased Fecal Human β-Defensin-2.

Authors:  Robert J Shulman; Sridevi Devaraj; Margaret Heitkemper
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-20       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.